207
Participants
Start Date
November 30, 2009
Primary Completion Date
September 30, 2010
Study Completion Date
September 30, 2010
PF-03463275
30 mg Controlled Release tablet BID for 12 weeks
Placebo
Placebo tablet BID
Pfizer Investigational Site, Staten Island
Pfizer Investigational Site, Staten Island
Pfizer Investigational Site, Fresh Meadows
Pfizer Investigational Site, Holliswood
Pfizer Investigational Site, Philadelphia
Pfizer Investigational Site, Washington D.C.
Pfizer Investigational Site, Washington D.C.
Pfizer Investigational Site, Atlanta
Pfizer Investigational Site, Atlanta
Pfizer Investigational Site, Decatur
Pfizer Investigational Site, Atlanta
Pfizer Investigational Site, Memphis
Pfizer Investigational Site, Flowood
Pfizer Investigational Site, Park Ridge
Pfizer Investigational Site, Wichita
Pfizer Investigational Site, Wichita
Pfizer Investigational Site, Edmond
Pfizer Investigational Site, Oklahoma City
Pfizer Investigational Site, Houston
Pfizer Investigational Site, Bellaire
Pfizer Investigational Site, Austin
Pfizer Investigational Site, Austin
Pfizer Investigational Site, Las Vegas
Pfizer Investigational Site, Las Vegas
Pfizer Investigational Site, Torrance
Pfizer Investigational Site, Cerritos
Pfizer Investigational Site, Paramount
Pfizer Investigational Site, Long Beach
Pfizer Investigational Site, Long Beach
Pfizer Investigational Site, Glendale
Pfizer Investigational Site, Chula Vista
Pfizer Investigational Site, National City
Pfizer Investigational Site, Escondido
Pfizer Investigational Site, Garden Grove
Pfizer Investigational Site, Runnemede
Pfizer Investigational Site, Toms River
Pfizer Investigational Site, Willingboro
Lead Sponsor
Pfizer
INDUSTRY